Medtech M&A took off in the first half of 2021, already eclipsing the number of deals made throughout 2020, and experts predict similar spending trends during the second half of this year, MedTech Dive reports.
Dealmaking started nearly as soon as 2021 began. Companies came out of the uncertainty of last year with large cash reserves and quickly put that money to work, with at least 10 deals announced in January alone.
While the pace of announced deals slowed from the break-neck speed of the first month of the year, multiple billion-dollar transactions and tuck-in acquisitions kept piling up. The medtech industry has recorded a total of 33 deals in the first half of 2021, up from 25 made in all of 2020. Read more.
